To include your compound in the COVID-19 Resource Center, submit it here.

Invokamet regulatory update

FDA approved an sNDA from Johnson & Johnson for Invokamet canagliflozin/metformin to improve

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE